PancrImmune

Pancreatic cancer has the worst survival of any human cancer, and tumours are known to be extremely aggressive with minimal response to conventional systemic therapy.

In 2019, Dr Rachael Bashford-Rogers and Dr Shivan Sivakumar launched PancrImmune: the Oxford Pancreatic Network, which brings together the experimental, clinical and statistical expertise from across the Oxford ecosystem to investigate the immune microenvironment of pancreatic pathologies and plan novel therapeutic strategies for improving patient outcome.

Across the network, there are researchers and clinicians pioneering work across 12 core themes to truly understand the pancreas, how it causes such significant but varying diseases, and unlock the potential to treat pancreatic cancer.

PancrImmune is funded by grants including the Wellcome Trust.

Through focusing on 12 core themes in pancreatic biology, the Oxford Pancreatic Network aims to publish world-leading, high-impact research that will produce novel trials that can change the outcome of pancreatic diseases.

A full list of members currently participating in collaborative pancreatic projects in Oxford